FEops' cutting-edge technology transforms cardiac images into digital twins, virtual copies of the heart or its substructures. With this technology, FEops aims to improve and expand personalized management for patients with structural heart disease. It’s FEops vision that combining digital twins with AI-enabled anatomical analyses generates data-driven insights aspiring to enhance and improve structural heart disease management, spanning from patient selection, procedure planning, periprocedural guidance to patient follow-up. The CE-marked and FDA-cleared FEops HEARTguide technology enables healthcare professionals to improve both procedure efficiency and clinical outcomes. It also empowers Medtech companies to bring superior products to the market faster than ever before